Our Company
About Saadia Pharmaceuticals
Our Team
Corporate Compliance
Our Science
Our Pipeline
News
Investors
Contact Us
Menu
Our Company
About Saadia Pharmaceuticals
Our Team
Corporate Compliance
Our Science
Our Pipeline
News
Investors
Contact Us
Contact Us
Home Page
/
News
/
Saadia Pharmaceuticals’ Team Publishes Commentary in CNS Drugs
Saadia Pharmaceuticals’ Team Publishes Commentary in CNS Drugs
Share an article:
Other News
September 10, 2024
In The News
Saadia Pharmaceuticals’ Team Gets Published in Nature
Learn More
September 6, 2024
In The News
Saadia Pharmaceuticals’ Team Featured in Yale Psychiatry News
Learn More
August 7, 2024
In The News
Saadia Pharmaceuticals’ Team Delivers NEI Podcast Discussing Vraylar®(Abbvie).
Learn More
July 27, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Publishes Spravato® (Janssen) Review Article in Biomarkers in Neuropsychiatry
Learn More
June 7, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Gives Presentation to 900K Prescribers on Vumedi
Learn More
May 15, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Publishes Rebutal on Vraylar® (AbbVie Pharmaceuticals) study on use for Bipolar I Disorder Maintenance
Learn More
